Efficacy and safety of immune checkpoint inhibitors in gastric cancer: a network meta-analysis of well-designed randomized controlled trials

BACKGROUND: Immune checkpoint inhibitors (ICIs) that inhibit the programmed death 1 (PD-1)/programmed death-ligand 1 (PD-L1) and cytotoxic T-lymphocyte antigen 4 (CTLA-4) interactions have shown promising prospects as treatment options for advanced gastric cancer (AGC). This manuscript analyzed well...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Siwei, Li, Kai, Huang, Baojun, Huang, Jinyu, Xu, Huimian, Zhu, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944325/
https://www.ncbi.nlm.nih.gov/pubmed/33708917
http://dx.doi.org/10.21037/atm-20-6639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944325/
https://www.ncbi.nlm.nih.gov/pubmed/33708917
http://dx.doi.org/10.21037/atm-20-6639

Ejemplares similares